175 related articles for article (PubMed ID: 29409939)
1. A new soluble and bioactive polymorph of praziquantel.
Zanolla D; Perissutti B; Passerini N; Chierotti MR; Hasa D; Voinovich D; Gigli L; Demitri N; Geremia S; Keiser J; Cerreia Vioglio P; Albertini B
Eur J Pharm Biopharm; 2018 Jun; 127():19-28. PubMed ID: 29409939
[TBL] [Abstract][Full Text] [Related]
2. Combining Mechanochemistry and Spray Congealing for New Praziquantel Pediatric Formulations in Schistosomiasis Treatment.
Albertini B; Perissutti B; Bertoni S; Zanolla D; Franceschinis E; Voinovich D; Lombardo F; Keiser J; Passerini N
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30870971
[TBL] [Abstract][Full Text] [Related]
3. Exploring mechanochemical parameters using a DoE approach: Crystal structure solution from synchrotron XRPD and characterization of a new praziquantel polymorph.
Zanolla D; Perissutti B; Vioglio PC; Chierotti MR; Gigli L; Demitri N; Passerini N; Albertini B; Franceschinis E; Keiser J; Voinovich D
Eur J Pharm Sci; 2019 Dec; 140():105084. PubMed ID: 31626966
[TBL] [Abstract][Full Text] [Related]
4. Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy.
Bellur Atici E; Karlığa B
J Pharm Biomed Anal; 2015 Oct; 114():330-40. PubMed ID: 26099262
[TBL] [Abstract][Full Text] [Related]
5. Mechanochemical Formation of Racemic Praziquantel Hemihydrate with Improved Biopharmaceutical Properties.
Zanolla D; Hasa D; Arhangelskis M; Schneider-Rauber G; Chierotti MR; Keiser J; Voinovich D; Jones W; Perissutti B
Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32210129
[TBL] [Abstract][Full Text] [Related]
6. Activity and pharmacokinetics of a praziquantel crystalline polymorph in the Schistosoma mansoni mouse model.
Lombardo FC; Perissutti B; Keiser J
Eur J Pharm Biopharm; 2019 Sep; 142():240-246. PubMed ID: 31265895
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of a new solid form of praziquantel, an essential anthelmintic drug. Praziquantel racemic monohydrate.
Salazar-Rojas D; Maggio RM; Kaufman TS
Eur J Pharm Sci; 2020 Apr; 146():105267. PubMed ID: 32061654
[TBL] [Abstract][Full Text] [Related]
8. A new polymorph of ciprofloxacin saccharinate: Structural characterization and pharmaceutical profile.
Singh P; Chadha R
J Pharm Biomed Anal; 2017 Nov; 146():7-14. PubMed ID: 28841428
[TBL] [Abstract][Full Text] [Related]
9. An explorative analysis of process and formulation variables affecting comilling in a vibrational mill: The case of praziquantel.
Beatrice Perissutti ; Passerini N; Trastullo R; Keiser J; Zanolla D; Zingone G; Voinovich D; Albertini B
Int J Pharm; 2017 Nov; 533(2):402-412. PubMed ID: 28552799
[TBL] [Abstract][Full Text] [Related]
10. Solid-State Characterization of Spironolactone 1/3 Hydrate.
Lemos Barbosa TW; Doriguetto AC; Benjamim de Araújo M; Bonfilio R
J Pharm Sci; 2019 Jul; 108(7):2458-2464. PubMed ID: 30853514
[TBL] [Abstract][Full Text] [Related]
11. Study on Enhanced Dissolution of Azilsartan-Loaded Solid Dispersion, Prepared by Combining Wet Milling and Spray-Drying Technologies.
Lu T; Sun Y; Ding D; Zhang Q; Fan R; He Z; Wang J
AAPS PharmSciTech; 2017 Feb; 18(2):473-480. PubMed ID: 27116201
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol cocrystals with enhanced solubility and tabletability.
Zhou Z; Li W; Sun WJ; Lu T; Tong HHY; Sun CC; Zheng Y
Int J Pharm; 2016 Jul; 509(1-2):391-399. PubMed ID: 27282539
[TBL] [Abstract][Full Text] [Related]
14. Co-grinding with surfactants as a new approach to enhance in vitro dissolution of praziquantel.
Gaggero A; Jurišić Dukovski B; Radić I; Šagud I; Škorić I; Cinčić D; Jug M
J Pharm Biomed Anal; 2020 Sep; 189():113494. PubMed ID: 32745904
[TBL] [Abstract][Full Text] [Related]
15. Novel polymorph of ambrisentan: Characterization and stability.
Haneef J; Chadha R; Gupta V; Mandal SK
J Pharm Biomed Anal; 2018 May; 153():102-109. PubMed ID: 29475138
[TBL] [Abstract][Full Text] [Related]
16. Structural characterization and enantioseparation of the chiral compound praziquantel.
Liu Y; Wang X; Wang JK; Ching CB
J Pharm Sci; 2004 Dec; 93(12):3039-46. PubMed ID: 15514924
[TBL] [Abstract][Full Text] [Related]
17. Solid state characterization of azelnidipine-oxalic acid co-crystal and co-amorphous complexes: The effect of different azelnidipine polymorphs.
Pan Y; Pang W; Lv J; Wang J; Yang C; Guo W
J Pharm Biomed Anal; 2017 May; 138():302-315. PubMed ID: 28237872
[TBL] [Abstract][Full Text] [Related]
18. Development of flexible and dispersible oral formulations containing praziquantel for potential schistosomiasis treatment of pre-school age children.
Trastullo R; Dolci LS; Passerini N; Albertini B
Int J Pharm; 2015 Nov; 495(1):536-550. PubMed ID: 26386139
[TBL] [Abstract][Full Text] [Related]
19. Transformation under pressure: Discovery of a novel crystalline form of anthelmintic drug Praziquantel using high-pressure supercritical carbon dioxide.
MacEachern L; Kermanshahi-Pour A; Mirmehrabi M
Int J Pharm; 2022 May; 619():121723. PubMed ID: 35395364
[TBL] [Abstract][Full Text] [Related]
20. Lisinopril dihydrate: single-crystal x-ray structure and physicochemical characterization of derived solid forms.
Sorrenti M; Catenacci L; Cruickshank DL; Caira MR
J Pharm Sci; 2013 Oct; 102(10):3596-603. PubMed ID: 23873413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
